Publications by authors named "JM Rowe"

Claim this Profile
M
Mass Balance and Metabolism of C-Atogepant in Healthy Male Participants: Findings of a Phase 1 Clinical Trial.
Ramesh R Boinpally, Pushpa Chandrasekar, Joshua M Rowe

Clin Transl Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying Hydrolytic Enzymes in the Vitreous Humor of Humans and Nonhuman Species Using Targeted Proteomics.
Sarah M Ruttenberg, Joshua M Rowe, Alireza Abdolvahabi

J Proteome Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-injection experiences among transgender people on injectable gender-affirming hormone therapy: A narrative review.
Jordan M Rowe, Sarah McBane, Jackson T Warner, Lauren R Cirrincione

J Am Pharm Assoc (2003)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.
Meira Yisraeli Salman, Alexander R Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Jacob M Rowe

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features.
Ilaria Iacobucci, Andy G X Zeng, Qingsong Gao, Laura Garcia-Prat, Pradyumna Baviskar, Jacob M Rowe

Nat Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Even with exposure to errors, motor imagery cannot update internal models.
Juliet M Rowe, Brooke C Cramer, Shaun G Boe

Psychol Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study.
Joseph P McGuirk, Leland Metheny, Luis Pineiro, Mark Litzow, Scott D Rowley, Jacob M Rowe

Bone Marrow Transplant· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot study.
Chezi Ganzel, Avraham Frisch, Ofir Wolach, Yakir Moshe, Baher Krayem, Jacob M Rowe

Br J Haematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the CONS.
Yishai Ofran, Jacob M Rowe

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlike overt movement, motor imagery cannot update internal models.
Juliet M Rowe, Shaun G Boe

Brain Cogn· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Pölönen, Jacob M Rowe

Cancer Discov· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Confocal Raman Microspectroscopy to Evaluate Skin Penetration of Topically Applied Substances.
Soonjin Hong, Prithwiraj Maitra, Kuniko Kadoya, Alireza Abdolvahabi, Joshua M Rowe

J Invest Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.
C Ganzel, Y Wang, K Roopcharan, Z Sun, J M Rowe

Bone Marrow Transplant· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.
C Ganzel, Y Wang, K Roopcharan, Z Sun, J M Rowe

Bone Marrow Transplant· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, Elisabeth M Paietta, Kathryn G Roberts, Jacob M Rowe

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?
Ofrat Beyar-Katz, Jacob M Rowe

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
Jessica K Altman, Tsila Zuckerman, Jamie Koprivnikar, James McCloskey, Vamsi Kota, Jacob M Rowe

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
War and peace: Israeli physicians treating Palestinian patients.
Shifra Ash, Tsila Zuckerman, Jacob M Rowe

Lancet· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
Ilaria Iacobucci, Andy G X Zeng, Qingsong Gao, Laura Garcia-Prat, Pradyumna Baviskar, Jacob M Rowe

bioRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study.
Joseph P McGuirk, Leland Metheny, Luis Pineiro, Mark Litzow, Scott D Rowley, Jacob M Rowe

Bone Marrow Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.
Shunsuke Kimura, Petri Polonen, Lindsey Montefiori, Chun Shik Park, Ilaria Iacobucci, Jacob M Rowe

medRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
Susan DeWolf, Martin S Tallman, Jacob M Rowe, Meira Yisraeli Salman

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.
James M Foran, Zhuoxin Sun, Catherine Lai, Hugo F Fernandez, Larry D Cripe, Jacob M Rowe

Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The increasingly blurred line between induction, consolidation and maintenance in acute myeloid leukaemia.
Avi Frisch, Jacob M Rowe, Yishai Ofran

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.
Chezi Ganzel, Zhuoxin Sun, Timour Baslan, Yanming Zhang, Mithat Gönen, Jacob M Rowe

Leuk Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis